SMC3 and ventricular septal defect: We extracted DNA samples for Sanger sequencing from 56 individuals with isolated CHD, including those with TOF and VSD, corresponding to the heart defects observed in SMC3-cKO mice, to understand the relevance of SMC3 variants in CHD patients without a distinct CdLS phenotype.